Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer.

[1]  J. Michałowicz,et al.  Apoptosis-Inducing Potential of Selected Bromophenolic Flame Retardants 2,4,6-Tribromophenol and Pentabromophenol in Human Peripheral Blood Mononuclear Cells , 2022, Molecules.

[2]  Ajay P. Jayan,et al.  A pharmacological exploration of targeted drug therapy in non-small cell lung cancer , 2022, Medical Oncology.

[3]  Weiguo Xiang,et al.  Therapeutic Strategies to Target the Androgen Receptor. , 2022, Journal of medicinal chemistry.

[4]  K. Chin,et al.  Modeling prostate cancer: What does it take to build an ideal tumor model? , 2022, Cancer letters.

[5]  Liangdao Cheng,et al.  Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: An Updated Review. , 2022, Human pathology.

[6]  R. Henrique,et al.  From Therapy Resistance to Targeted Therapies in Prostate Cancer , 2022, Frontiers in Oncology.

[7]  C. V. Oztekin,et al.  An update on the current status and future prospects of erectile dysfunction following radical prostatectomy , 2022, The Prostate.

[8]  Tanya Stoyanova,et al.  Molecular Mechanisms Underlying the Development of Neuroendocrine Prostate Cancer. , 2022, Seminars in cancer biology.

[9]  C. Lungu,et al.  Anticancer Activity of Natural and Synthetic Chalcones , 2021, International journal of molecular sciences.

[10]  R. Bristow,et al.  Prostate cancer , 2021, The Lancet.

[11]  V. Pongrakhananon,et al.  Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products , 2021, Molecules.

[12]  Angelina I. Nikitkina,et al.  Cathepsin D—Managing the Delicate Balance , 2021, Pharmaceutics.

[13]  Yang Ouyang,et al.  Chalcone Derivatives: Role in Anticancer Therapy , 2021, Biomolecules.

[14]  B. Liagre,et al.  Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy. , 2021, European journal of medicinal chemistry.

[15]  Shweta Jain,et al.  Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy , 2021, Chemical biology & drug design.

[16]  K. Izumi,et al.  α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer , 2021, Molecules.

[17]  Paul Awolade,et al.  Recent advances in chalcone-based anticancer heterocycles: A structural and molecular target perspective. , 2021, Current medicinal chemistry.

[18]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[19]  T. H. van der Kwast,et al.  Prostate cancer , 2021, Nature Reviews Disease Primers.

[20]  Xunxia Bao,et al.  Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis , 2020, Frontiers in Oncology.

[21]  R. Shiri-Sverdlov,et al.  The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management , 2020, Cells.

[22]  F. Gao,et al.  Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship. , 2020, Medicinal research reviews.

[23]  P. Dai,et al.  Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene. , 2020, Life sciences.

[24]  J. Bajorath,et al.  Can Cysteine Protease Cross-class Inhibitors Achieve Selectivity? , 2019, Journal of medicinal chemistry.

[25]  Muh-Hwa Yang,et al.  Caspase-3, a key apoptotic protein, as a prognostic marker in gastric cancer after curative surgery. , 2018, International journal of surgery.

[26]  G. Çiftçi,et al.  Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents. , 2017, Anti-cancer agents in medicinal chemistry.

[27]  Zhuorong Li,et al.  Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K. , 2018, Bioorganic & medicinal chemistry.

[28]  S. Büttner,et al.  Taking out the garbage: cathepsin D and calcineurin in neurodegeneration , 2017, Neural regeneration research.

[29]  S. Patil,et al.  Recent developments in biological activities of indanones. , 2017, European journal of medicinal chemistry.

[30]  Gang Chen,et al.  A natural chalcone induces apoptosis in lung cancer cells: 3D-QSAR, docking and an in vivo/vitro assay , 2017, Scientific Reports.

[31]  M. Previati,et al.  Calcium regulates cell death in cancer: Roles of the mitochondria and mitochondria-associated membranes (MAMs). , 2017, Biochimica et biophysica acta. Bioenergetics.

[32]  Suaib Luqman,et al.  Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents. , 2017, Current cancer drug targets.

[33]  C. Xing,et al.  Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.

[34]  José C J M D S Menezes,et al.  Arylidene indanone scaffold: medicinal chemistry and structure–activity relationship view , 2017 .

[35]  Liwu Fu,et al.  Targeting calcium signaling in cancer therapy , 2016, Acta pharmaceutica Sinica. B.

[36]  D. Averill-Bates,et al.  Activation of apoptosis signalling pathways by reactive oxygen species. , 2016, Biochimica et biophysica acta.

[37]  Suaib Luqman,et al.  Anticancer activity of gallic acid template‐based benzylidene indanone derivative as microtubule destabilizer , 2016, Chemical biology & drug design.

[38]  H. Temel,et al.  Synthesis and Evaluation of New Benzodioxole- Based Thiosemicarbazone Derivatives as Potential Antitumor Agents , 2016, Molecules.

[39]  D. Pastorelli,et al.  Therapeutic management of bone metastasis in prostate cancer: an update , 2016, Expert review of anticancer therapy.

[40]  N. Duran,et al.  Synthesis and anti-proliferative activity of fluoro-substituted chalcones. , 2016, Bioorganic & medicinal chemistry letters.

[41]  T. Zhu,et al.  Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer , 2016, International journal of molecular sciences.

[42]  Jinhui Hu,et al.  Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo. , 2016, Journal of medicinal chemistry.

[43]  B. Sarmento,et al.  Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy. , 2015, Current drug targets.

[44]  J. Joyce,et al.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response , 2015, Nature Reviews Cancer.

[45]  N. Gutowski,et al.  The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer , 2015, Biomolecules.

[46]  D. Siemann,et al.  Cathepsin L targeting in cancer treatment. , 2015, Pharmacology & therapeutics.

[47]  Suaib Luqman,et al.  Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  E. Francini,et al.  Targeted Therapies for Prostate Cancer , 2015, Cancer investigation.

[49]  C. Scott,et al.  Cathepsin S: therapeutic, diagnostic, and prognostic potential , 2015, Biological chemistry.

[50]  Vivek Asati,et al.  Anti-cancer chalcones: Structural and molecular target perspectives. , 2015, European journal of medicinal chemistry.

[51]  B. Zhivotovsky,et al.  Calcium and mitochondria in the regulation of cell death. , 2015, Biochemical and biophysical research communications.

[52]  A. Whetton,et al.  Molecular histology of lung cancer: from targets to treatments. , 2015, Cancer treatment reviews.

[53]  G. Çiftçi,et al.  Synthesis and evaluation of new indole-based chalcones as potential antiinflammatory agents. , 2015, European journal of medicinal chemistry.

[54]  E. Manivannan,et al.  Advances in chalcones with anticancer activities. , 2014, Recent patents on anti-cancer drug discovery.

[55]  Rakesh Kumar,et al.  A Review on Mechanisms of Anti Tumor Activity of Chalcones. , 2015, Anti-cancer agents in medicinal chemistry.

[56]  C. Mai,et al.  Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins. , 2014, European journal of medicinal chemistry.

[57]  Yan-Bing Zhang,et al.  Molecular targeted approaches to cancer therapy and prevention using chalcones. , 2014, Current cancer drug targets.

[58]  G. Çiftçi,et al.  Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity , 2013, Journal of enzyme inhibition and medicinal chemistry.

[59]  Y. Na,et al.  Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents. , 2013, Bioorganic & medicinal chemistry letters.

[60]  Freddie L. Pruitt,et al.  Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium , 2013, The Prostate.

[61]  P. Di Sebastiano,et al.  Cathepsins and pancreatic cancer: the 2012 update. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[62]  S. Boorjian,et al.  Overcoming Drug Resistance and Treating Advanced Prostate Cancer , 2012, Current drug targets.

[63]  Atul Gupta,et al.  Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization. , 2012, Bioorganic & medicinal chemistry.

[64]  N. Sahu,et al.  Exploring pharmacological significance of chalcone scaffold: a review. , 2012, Current medicinal chemistry.

[65]  J. Porco,et al.  Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro. , 2011, Biochemical and biophysical research communications.

[66]  Shekhar Bhansali,et al.  Lung cancer and its early detection using biomarker-based biosensors. , 2011, Chemical reviews.

[67]  A. Vines,et al.  A flow‐cytometric method for continuous measurement of intracellular Ca2+ concentration , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[68]  R. Kurzrock,et al.  Targeted therapy in non-small-cell lung cancer—is it becoming a reality? , 2010, Nature Reviews Clinical Oncology.

[69]  A. H. van der Spek,et al.  Cathepsin L, target in cancer treatment? , 2010, Life sciences.

[70]  S. Mousa,et al.  Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy. , 2008, Biochimica et biophysica acta.

[71]  P. Pinton,et al.  Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis , 2008, Oncogene.

[72]  M. Michaelson,et al.  Management of Complications of Prostate Cancer Treatment , 2008, CA: a cancer journal for clinicians.

[73]  A. Katz.  Quality of Life for Men With Prostate Cancer , 2007, Cancer nursing.

[74]  O. Vasiljeva,et al.  Emerging roles of cysteine cathepsins in disease and their potential as drug targets. , 2007, Current pharmaceutical design.

[75]  V. Laurent-Matha,et al.  Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. , 2006, Cancer letters.

[76]  H. Cottam,et al.  Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. , 2000, Journal of the National Cancer Institute.

[77]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.